分析中国应采取的战略,以应对全球百日咳趋势
相关实验视频
Updated: May 23, 2025

08:52
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
10.6K
Shuying Jiang1, Chunyan Wu2, Zhenhua Zhu3
1Department of Pharmacy, Taizhou Central Hospital (Taizhou University Hospital), Taizhou, China.
Human vaccines & immunotherapeutics
|May 22, 2025
概括
全球范围内百日咳 (百日咳) 正在复苏,特别是在COVID-19后,所有年龄组的病例都在增加. 目前的百日咳疫苗接种策略存在差距,需要改进疫苗开发和公共卫生干预措施.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
背景情况:
- 近年来,百日咳的发病率在全球范围内有所增加.
- 已经观察到咳的显著复苏,特别是在COVID-19大流行之后.
- 虽然婴儿受影响最多,但青少年和成年人中百日咳的发病率显著增加.
研究的目的:
- 为了突出各种年龄段越来越多的百日咳发病率.
- 发现当前百日咳疫苗接种指南中的缺陷.
- 强调需要加强研究,免疫,监测和公众意识.
主要方法:
- 审查最近的百日咳发病率数据.
- 分析目前的百日咳疫苗接种指南和覆盖范围.
- 评估婴儿,青少年和成人的疾病趋势.
主要成果:
- 报告的百日咳发病率在全球范围内不断增加.
- 在青少年和成年人中观察到咳病例的显著增加.
- 目前的疫苗接种策略显示,关键人口统计数据的覆盖率存在差距.
结论:
- 迫切需要通过改进的疫苗接种策略来解决百日咳的复发问题.
- 加强对新型百日咳疫苗的研究和开发至关重要.
- 加强免疫计划,监测和公众意识对于控制百日咳的传播至关重要.
关键词:
pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis pertussis接种疫苗 接种疫苗疫苗 疫苗 疫苗 疫苗更多相关视频
相关概念视频
Viral Recombination
23.2K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.2K
Viral Mutations
32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Pneumonia IV: Management
283
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
283
Steps in Outbreak Investigation
102
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
102
Pneumonia III: Complications and Assessment
137
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
137

